Background: Sleep disruptions are an important consequence of alcohol use disorders. There is a dearth of preclinical studies examining sex differences in sleep patterns associated with ethanol (EtOH) dependence despite documented sex differences in alcohol-related behaviors and withdrawal symptoms. The purpose of this study was to investigate the effects of chronic intermittent EtOH on sleep characteristics in female and male mice.
A LCOHOL USE DISORDER is a psychiatric disease characterized by a loss of control over the ingestion of alcohol, compulsive use of alcohol, and the presence of withdrawal symptoms when the ingestion of alcohol is stopped (https://www.niaaa.nih.gov/alcohol-health/overview-alcoholconsumption/alcohol-use-disorders). Some of the most frequent disturbances reported during alcohol withdrawal include irritability, sweating, tremors, and anxiety (Sachdeva et al., 2015) . In addition to the aforementioned disturbances, sleep abnormalities during acute and chronic alcohol intoxication have been reported, as well as during alcohol withdrawal. Sleep impairments include difficulty falling asleep, frequent awakening, daytime sleepiness, abnormal sleep quality, and insomnia (Brower, 2001; Chaudhary et al., 2015; Colrain et al., 2014; Ebrahim et al., 2013) . These sleep alterations negatively affect many aspects of life for the alcoholic, including deficits in learning and memory process, emotional stability, and job performance (Chakravorty et al., 2014; Chaudhary et al., 2015) . Importantly, sleep disturbances associated with alcohol withdrawal are considered important predictors of relapse (Brower et al., 1998 . Indeed, Gillin and colleagues (1994) reported that increased levels of rapid eye movement (REM) sleep, and reduced REM sleep latency in alcoholics predicted relapse to drinking within the first months of abstinence, while Brower and colleagues (2001) reported that insomnia may delay recovery from alcohol addiction and precipitate relapse within the first stages of recovery. Thus, sleep improvement is considered an important target for treatments for alcoholism (Brower, 2015; Kolla et al., 2011) .
Sex differences in humans have been reported in patterns of ethanol (EtOH) drinking, abuse, physiological responses (Nolen-Hoeksema, 2004; Wilsnack et al., 2000) , withdrawal (Devaud et al., 2006) , and relapse (Boykoff et al., 2010) , and women are considered more sensitive to EtOH-related or EtOH withdrawal-induced harm than men (Hommer, 2003) . Effects of sex on alcohol-related sleep disturbances have been investigated; however, larger sample sizes of female and male alcoholics are needed for a more complete understanding of potential sex differences (Colrain et al., 2014) . For example, while no sex differences were noted in a study of insomnia in treatment seeking alcoholics, only 26 of the 172 subjects were female . In a more balanced study (59 women, 34 men), albeit using healthy nonalcoholic subjects, it was shown that equal blood alcohol levels were associated with greater disruptions in sleep in the women (Arnedt et al., 2011) . Finally, Colrain and colleagues (2009) studied recovering alcoholics (15 women, 27 men) and found no significant sex differences, although alcoholic men seemed to show a larger reduction in delta activity during non-REM sleep relative to male controls than female alcoholics did compared to female controls. Male and female subjects had different alcohol histories and lengths of sobriety arguing for the need for larger, more balanced studies.
While no animal model of EtOH dependence and withdrawal fully emulates the human condition, several behavioral and neurochemical impairments observed in alcoholics can be satisfactorily produced in animal models. Indeed, it has been reported that administration of EtOH through several routes, including vapor chambers, intragastric dosing, drinking, and liquid diets, causes disruptions in sleep in rats. These alterations include increases in the amount of wakefulness, reductions in the amount of sleep, changes in REM sleep, and modifications in the electroencephalographic (EEG) power spectrum during EtOH withdrawal (Gitlow et al., 1973; Kubota et al., 2002; Mendelson et al., 1978; Mukherjee and Simasko, 2009; Mukherjee et al., 2008; Rouhani et al., 1998; Thakkar et al., 2015) . For example, while Ehlers and Slawecki (2000) reported no changes in the amount of slow-wave sleep (SWS) immediately following EtOH exposure and 5 weeks after EtOH withdrawal, they did find a significant reduction in the EEG power spectrum of delta, theta, and beta bands, suggesting disruptions in sleep quality. Like rats, mice also show disturbances in both the amount and architecture of sleep during repeated chronic EtOH exposure and withdrawal episodes (Veatch, 2006) . In this case, increases in REM sleep and decreases in non-REM sleep were observed with the latter normalizing by the fourth day of withdrawal.
Although the above-mentioned studies provide important information about EtOH withdrawal sleep alterations in rodents, all of them have been performed exclusively in males. The lack of information regarding EtOH withdrawalrelated sleep alterations in females is surprising as there are important sex differences in EtOH-related behaviors in general and withdrawal specifically (Becker and Koob, 2016; Finn et al., 2010) . In fact, it has been shown that male rodents generally have both a greater withdrawal response and a slower recovery from EtOH withdrawal than female rodents. For example, Reilly and colleagues (2009) reported that male rats showed a significant increase in startle reflex during EtOH withdrawal, while females and ovariectomized female rats showed small to no changes compared to controls. Likewise, it has been shown that male rats (Devaud and Chadda, 2001 ) and mice (Veatch et al., 2007) had greater seizure susceptibility than females during EtOH withdrawal. Additionally, it has been reported that male rats had a greater anxiety-like response, measured by the suppression of social interaction, than female rats during withdrawal (Varlinskaya and Spear, 2004) . Male rodents are not necessarily more sensitive than females in all cases. For example, female rodents drink more EtOH than males (e.g., Belknap et al., 1993; Chester et al., 2008; Finn et al., 2004; Lancaster et al., 1996; Torres et al., 2014; Yoneyama et al., 2008) and show a bigger increase in both corticosterone and adrenocorticotropic hormone levels following acute EtOH (Rivier, 1993) , and greater EtOH-induced hypothermia (Webb et al., 2002) relative to males.
Given the documented sex differences in EtOH-related, and especially EtOH withdrawal-related behaviors and the importance of sleep disturbances in increasing the negative reinforcing aspects of EtOH, it is of critical importance to examine the effects of chronic EtOH exposure on sleep in both males and females. The chronic intermittent EtOH (CIE) model is used, which allows for the examination of sleep in mice that have a history of EtOH drinking combined, in the dependent group, with passive EtOH vapor exposure. We have focused on 4 days into withdrawal, after acute withdrawal signs have subsided, but when dependent mice show increased EtOH drinking (Becker and Lopez, 2004) .
MATERIALS AND METHODS

Animals
Adult female and male C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) were used in this study. Body weights averaged 22.20 g (females) and 28.42 g (males) at the start of the experiment. Mice were housed 4 per cage (except during the 2-hour drinking sessions) separated by sex in standard plastic cages on a reversed 12-hour light/dark period (lights on at 8:00 PM), with food and water available ad libitum. All procedures were IACUC-approved and met the guidelines of the National Institute of Health detailed in the Guide for the Care and Use of Laboratory Animals.
CIE 2-Bottle Choice Consumption
In the CIE 2-bottle choice (CIE-2BC) drinking procedure used in this study, animals exhibit increased alcohol intake in a limitedaccess EtOH/water choice after chronic passive exposure to EtOH vapor. This procedure has been successfully used in rats (Vendruscolo and Roberts, 2014) and C57BL/6J mice (Becker and Lopez, 2004; Finn et al., 2007; Griffin et al., 2009 ) to model the motivational aspects of EtOH dependence and excessive EtOH drinking associated with the addicted state. In brief, for the first 15 days of testing (5 days per week for 3 weeks), 30 minutes before the lights went off (7:30 AM), mice were individually housed for 2 hours with access to 2 drinking tubes, one containing 15% EtOH (v/v, prepared with ethyl alcohol 200 proof; Pharmco-AAPER, Brookfield, CT) and the other containing water. EtOH and water consumption during the 2-hour period was recorded. Following this baseline period of drinking, mice were divided by sex, based on equal EtOH and water consumption, into 2 balanced treatment groups that were exposed to intermittent EtOH vapor (17 male and 14 female mice, the vapor-2BC group) or air in identical chambers (20 male and 16 female mice, the control-2BC group). Chambers consisted of standard plastic mouse-sized shoebox cages containing up to 4 mice per chamber (La Jolla Alcohol Research Inc., La Jolla, CA). EtOH vapor was created by pumping 95% EtOH into a 2-l Erlenmeyer vacuum flask (Fisher Scientific, Waltham, MA) kept at 50°C on a warming tray. Air was blown over the bottom of the flask at a rate of 11 l/min. Concentrations of EtOH vapor were adjusted by varying the rate at which the EtOH was pumped into the flask which, in turn, was based on the blood alcohol levels of the mice. Vapor chamber concentrations were adjusted to match blood alcohol levels of females and males and were 2.47 AE 0.01% for female and 2.87 AE 0.01% for males. The EtOH vapor-2BC group was injected with 1.75 g/kg EtOH and 68.1 mg/kg pyrazole (alcohol dehydrogenase inhibitor; Sigma-Aldrich, St. Louis, MO) and placed in the chambers to receive vapor for 16 hours (with 8 hours off). Following the fourth day of exposure, mice were allowed 72 hours of undisturbed time in their home cages. The mice were then given 5 days of access to 2 bottles containing 15% EtOH or water for 2 hours to measure EtOH drinking. The 4 days of vapor or air exposure and 5 days of 2BC testing were repeated for a total of 4 cycles plus another cycle of only the vapor/air following surgery and recovery (see below). The control-2BC group was injected with 68.1 mg/kg pyrazole in 0.9% saline and placed in chambers delivering air for the same periods as the EtOH vapor group and received 2BC testing at the same time as the vapor group. Two additional groups of na€ ıve mice (20 male and 8 female mice) were never treated with EtOH or pyrazole. Following each 16-hour bout of EtOH vapor exposure, mice were removed and on the third day of each cycle, and tail blood was sampled for blood alcohol levels. Blood was collected in capillary tubes and emptied into 1.5-ml centrifuge tubes containing evaporated heparin and kept on ice. Samples were centrifuged, and serum was decanted into fresh 1.5-ml centrifuge tubes. The serum was injected into an oxygen-rate alcohol analyzer (Analox Instruments, Lunenburg, MA) for blood alcohol level determination. Five pairs of EtOH standards (0.5 to 3.0 mg/ml) were analyzed prior to the samples. Target blood alcohol levels were 200 to 250 mg%. After the fourth cycle, EEG recording electrodes were implanted in all groups and, following recovery, mice in the vapor-2BC group received a fifth and final cycle of vapor exposure before recordings. The testing timeline is illustrated in Fig. 1 .
Surgical Procedure
All mice used in this study were implanted under isoflurane anesthesia (1 to 2%), with a standard set of stainless steel screw electrodes for chronic sleep recordings. The EEG was recorded from electrodes placed in the frontal and parietal bone over the hippocampus (P = À2.06; L = 1.5; H = 1.0 to bregma according to The Mouse Brain in Stereotaxic Coordinates) (Franklin and Paxinos, 2001) . A third EEG electrode was placed in the skull over the cerebellum and served to ground the animal to reduce signal artifacts. Two wire electrodes inserted in the neck musculature were used to record postural tone through electromyography (EMG) activity. Insulated leads from the EEG and EMG electrodes were then soldered to a miniconnector that was cemented to the skull with dental acrylic. During anesthetic recovery, mice were monitored for resumption of normal righting capability and locomotion. All mice were allowed a 1-week recovery. A total of 57 male and 38 female mice were implanted for electrophysiologic recordings. However, 1 male mouse from the vapor-2BC group, 2 male mice from the control-2BC group, and 2 male mice from the na€ ıve group died after surgery, whereas the EEG recording electrodes of 2 male mice from the control-2BC group and 3 mice from the na€ ıve group damaged their electrodes and they were not used in the study. Likewise, 1 female mouse from the na€ ıve group and 1 female mouse from the vapor-2BC group damaged their EEG electrodes. Therefore, a total of 47 male and 36 female mice were used.
Experimental Protocol and Data Acquisition
Two days after the last round of vapor (withdrawal) or control conditions, mice were connected to commutators with flexible cables allowing their unrestricted movement within the cage and were habituated to the recording cages for 48 hours. Without disturbing the animals, recordings began at the 4-day withdrawal point, after light onset (ZT-0; ZT = zeitgeber time), and the signals were continuously recorded from EEG and EMG electrodes across 24 hours. The EEG and EMG signals were amplified by a Grass Model 7D polygraph (Astro-Med, Icn Product Group, West Warwick, RI) in a frequency range of 0.30 to 70 Hz and sampled at 256 Hz. The EEG and EMG were displayed on a computer monitor and stored with a resolution of 128 Hz in the hard drive of a computer for the offline analysis of the sleep-wake states and spectral analysis using software supplied by Kissei-Comtec (Irvine, CA).
EEG Analysis
The polygraphic results were analyzed semi-automatically in 15-second epochs and classified according to the following stages of vigilance: wakefulness (W), SWS, and REM sleep, as described previously (Bourgin et al., 2007; Huitron-Resendiz et al., 2004) . Electrophysiologic criteria were used to define the sleep-wake stages, as follows: W was characterized by desynchronization of the EEG and high theta activity and the presence of muscle tone; SWS by highvoltage waves, high delta activity, and decreased voltage in the EMG; and REM sleep by desynchronization of the EEG, high theta activity, and absence of voltage in the EMG. Total time spent in W, SWS, and REM sleep in periods of 12 hours was calculated. The frequency, duration, and latency of the individual SWS and REM sleep episodes were evaluated. In addition to standard sleep analysis, EEG spectral analyses in the different sleep-wake stages were performed by Fourier fast transformer analysis using 4-second epochs, giving 0.25-Hz bins from 0 to 70 Hz. Each bin was named after its lower limit. Epochs with artifacts were excluded by software-visual review recognition of the polygraph records. In W, SWS, and REM sleep, only epochs that were both preceded and followed by the same stage were included in the analysis.
Statistical Analysis
We based group sizes on power analysis (https://www.dssresea rch.com/KnowledgeCenter/toolkitcalculators/statisticalpowercalcu lators.aspx) using previous data collected in our laboratory. Previous CIE studies involving control-2BC and vapor-2BC groups had powers of 0.75 with an N = 8, 0.83 with an N = 9, and 0.94 with an N = 12. For pilot studies looking at the effects of EtOH withdrawal on EEG, we started with an N = 4 and, using these data to calculate sample size, found that an N of 6 would be sufficient to achieve a power of 0.90 for EtOH/control comparisons. Based on these calculations, we started with larger Ns for the EtOH-drinking groups and somewhat smaller Ns for the na€ ıve groups that were only being used for the EEG comparisons and made sure we accounted for loss due to EtOH vapor chamber or surgical problems (described above). Final group sizes for the EtOH-na€ ıve groups were 7 females and 15 males; 16 females and 16 males for the control-2BC groups; and 13 females and 16 males for the vapor-2BC groups.
We followed recommendations provided by McCarthy (2015) and Guizzetti and colleagues (2016) to design and analyze experiments addressing sex as a biological variable and did not monitor the estrus cycle or perform gonadectomies in this initial study. Comparing and contrasting males and females may lead to the discovery of novel mechanisms related to EtOH withdrawal and sleep and the present findings could be used as a tool to interrogate sex differences in these processes.
Two-way repeated-measures analysis of variance (ANOVA) with the between-subject factor sex and the within-subject factor treatment (na€ ıve, control-2BC, and vapor-2BC) was used to assess differences in EtOH intake, vigilance states, and EEG power between groups during EtOH withdrawal. We examined the light and dark phases separately for sleep and EEG power as phase differences were expected, and we wanted to focus on group and sex differences. The Fisher's Partial Least-Squares Difference (PLSD) test was used for specific comparisons when indicated by the ANOVA. In addition, separate 1-way ANOVAs were performed to compare treatment effects in female and male mice. Significant main effects were further analyzed with post hoc analyses (Fisher's PLSD test) to compare sex differences. Results were considered significant with p < 0.05 for significance.
RESULTS
Our results showed that, overall, female mice drank more EtOH than males ( Fig. 2A: F(1, 57) = 34.65, p < 0.0001) and there was an overall significant effect of group, F(1, 57) = 20.64, p < 0.0001; however, CIE vapor exposure resulted in similar escalation of EtOH drinking in both sexes (i.e., no significant sex 9 group interaction, F(1, 228) = 1.55, p = 0.11). In fact, each of the CIE tests resulted in higher EtOH drinking than observed during baseline (p < 0.001). Blood alcohol levels associated with EtOH vapor exposure were similar in females and males, indicating that our adjustments in vapor concentrations were successful (Fig. 2B) .
Alterations in Vigilance States at 4 Days of EtOH Withdrawal
Each group of mice (na€ ıve, control-2BC, and vapor-2BC) used in the study showed expected increases in sleep during lights on and increases in wakefulness during lights off. However, statistical analysis showed a significant effect of group in the amount of W, F(2, 77) = 19.28, p < 0.0001, during the light period, with no significant effect of sex, F(1, 77) = 0.6, p = 0.44, or group 9 sex, F(2, 77) = 1.31, p = 0.28. Post hoc analysis revealed that the amount of W in the vapor-2BC mice was significantly higher than that of the na€ ıve and control-2BC groups (p = 0.0005 and p < 0.0001, respectively; Fig. 3A ). There was a concomitant group difference in SWS, F(2, 77) = 17.47, p < 0.0001, again with no effects involving sex. Post hoc analysis revealed that the amount of SWS in the light period for vapor-2BC groups was significantly lower than that of the na€ ıve and control-2BC groups (p = 0.0004 and p < 0.0001, respectively; Fig. 3B ). No significant group differences were observed in the amount of W during the dark period, F(2, 77) = 2.97, p = 0.06 (Fig. 3A) , but there was a significant effect of group on SWS during this phase, F(2, 77) = 3.18, p = 0.047. Post hoc analysis showed a significant decrease in SWS in vapor-2BC relative to na€ ıve mice (p = 0.02). However, again, there were no significant effects involving sex on W and SWS during the dark phase. These results suggested that a history of EtOH vapor decreases sleep quantity to a similar degree in female and male mice.
EtOH vapor exposure also resulted in alterations in REM sleep, but only during the light phase, F(2, 77) = 5.91, p = 0.004. In this phase, there was also an overall sex difference, F(1, 77) = 30.66, p < 0.0001, with males spending more time in REM than females. Because there was no significant group 9 sex interaction, F(2, 77) = 1.67, p = 0.19, post hoc analysis was done on sexes combined and revealed that vapor-2BC mice had reduced REM sleep during the light period, compared to control-2BC mice (p = 0.004; Fig. 3C ).
Alterations in overall sleep amounts could be due to changes in the duration and/or number of SWS episodes. Indeed, there was a significant effect of group on the duration of SWS episodes in the light phase (Fig. 4A : F(2, 77) = 4.21, p = 0.018, but also a significant group 9 sex interaction, F(2, 77) = 3.96, p = 0.023). Looking at the sexes separately, the group effect was only significant in males, F(2, 44) = 7.02, p = 0.002, not in females, F(2, 44) = 2.58, p = 0.09. Post hoc analysis showed that vapor-2BC male mice had significantly shorter episodes than na€ ıve and 2BC mice (p = 0.0005 and p = 0.041, respectively). A significant effect of group on duration of SWS episodes during the dark period was also observed, F(2, 77) = 4.54, p = 0.014, as was a significant overall effect of sex, F(1, 77) = 7.49, p = 0.0077. Because there was no significant group 9 sex interaction, F (2, 77) = 0.33, p = 0.72, post hoc analysis was done on sexes combined and revealed that vapor-2BC mice had significantly shorter sleep episodes than na€ ıve and 2-BC mice (p = 0.009 and p = 0.011, respectively).
The only significant effect on the number of SWS episodes was a group 9 sex interaction in the light phase (Fig. 4B : F(2, 77) = 6.46, p = 0.003). Only males had a significant group difference, F(2, 44) = 4.07, p = 0.023, with post hoc analysis revealing an increase in number of SWS episodes in vapor-2BC versus na€ ıve mice (p = 0.007). The increase in the number of SWS episodes and the reduction in the duration of SWS episodes could be considered a fragmentation of sleep, and because this was significant only in males during the light phase, these results suggest that chronic passive exposure to EtOH vapor and limited access to EtOH/water choice altered mechanisms associated with the maintenance of SWS to a greater degree in males.
Analysis of REM episode duration (Fig. 5A) and number (Fig. 5B ) revealed only trends involving group, with the only statistically significant effect being an overall sex difference in number of REM episodes during the light phase, F(1, 77) = 7.39, p = 0.008.
Because we found group differences in SWS, we were interested in examining the latency to fall asleep following lights on. Statistical analysis showed a significant effect of sex on the latency to the first SWS episode, F(2, 77) = 5.508, p < 0.0215. Post hoc analysis revealed that SWS latency was significantly increased in vapor-2BC females compared to the na€ ıve group (p = 0.0155). No significant differences were observed in males (Fig. 6A) . Likewise, statistical analysis Fig. 2 . Escalated EtOH drinking following chronic intermittent EtOH (CIE) (A), and blood alcohol levels during vapor exposure (B). Values (mean AE SEM) were compared using a 2-way ANOVA and Fisher's PLSD tests. Data are presented separately for males and females; however, the post hoc statistics were performed with sexes combined as there were no significant effects involving sex. Overall, EtOH intake was higher in each CIE test relative to baseline in the vapor-2BC group, with no change over tests in control-2BC mice. § §p < 0.05 versus control-2BC with sexes combined.
showed a significant effect of sex on the latency for the first REM sleep episode, F(2, 77) = 7.699, p < 0.0069. Post hoc analysis revealed that vapor-2BC female mice had a significant increase in the latency to REM compared to the na€ ıve and control-2BC groups (p = 0.046 and p = 0.043, respectively), whereas no significant differences were observed between groups in male mice (Fig. 6B) .
Taken together, these results strongly indicate that the chronic passive exposure to intermittent EtOH vapor plus limited-access EtOH/water 2BC causes important abnormalities in the regulation of SWS at 4 days of withdrawal, compared to na€ ıve and 2BC EtOH control mice. While the vapor-2BC group had decreased SWS independent of sex, males had decreased SWS episode duration and increased number of episodes and females had a decreased latency to SWS. This suggests that the underlying mechanisms for sleep disruption may be sex dependent.
The time course analysis of SWS is shown (Fig. 7) in order to illustrate hourly sleep across the groups. Overall, there were significant effects of group, F(2, 77) = 9.4, p = 0.0002, hour, F(23, 1,771) = 26.1, p < 0.0001, and sex 9 hour, F(23, 1,771) = 1.6, p = 0.03, with vapor-2BC mice having significantly less SWS than control-2BC (p = 0.0003) and na€ ıve (p = 0.0011) mice. The group 9 hour interaction was not significant; therefore, individual time points were not compared between groups.
Alterations in EEG Spectral Power at 4 Days of EtOH Withdrawal
Slow waves between 0.5 and 4.0 Hz (delta band) are predominant in SWS; waves between 6.0 and 12.0 Hz (theta band), 8.0 to 12.0 Hz (alpha band), 15.0 to 30.0 Hz (beta band), and 30.0 to 60 Hz (gamma band) are more consistently observed during W; and theta band between 4.0 and 9.0 Hz is more predominant during REM sleep (Borbely Values (mean AE SEM) were compared using a 2-way ANOVA and Fisher's PLSD tests. Data are presented separately for males and females; however, the post hoc statistics were performed with sexes combined as there were no significant effects involving sex. In the light phase, vapor-2BC mice had more time in W and less time in SWS than both control-2BC and na€ ıve mice. REM was significantly reduced in vapor-2BC mice as compared to control-2BC mice in the light phase. In the dark phase, vapor-2BC mice spent less time in SWS relative to na€ ıve mice. §p < 0.05 versus na€ ıve, § §p < 0.05 versus control-2BC, § § §p < 0.05 versus both control-2BC and na€ ıve, all with sexes combined.
Fig. 4. Slow-wave sleep (SWS) episode duration (A) and number of SWS episodes (B) 4 days into EtOH withdrawal. Values (mean AE SEM)
were compared using a 2-way ANOVA and Fisher's PLSD tests. Because there was a group 9 sex interaction in episode duration, sexes were examined separately, revealing that vapor-2BC males had significantly shorter episodes than control-2BC and na€ ıve males. There was a group difference in episode duration in the light phase, but no sex difference. Overall, vapor-2BC mice had shorter SWS episodes than both control groups. In the light phase, there was a group 9 sex interaction, with vapor-2BC males having more SWS episodes relative to na€ ıve males. *p < 0.05 versus na€ ıve, ***p < 0.05 versus control-2BC and na€ ıve, sexes analyzed separately, § § §p < 0.05 versus control-2BC and na€ ıve, sexes combined.
et al., 1984; Huitron-Resendiz et al., 2004) . Therefore, we analyzed and compared the mean EEG spectral power for specific frequency bands during W, SWS, and REM sleep. Results showed a significant effect of treatment on delta power during SWS at 4 days of withdrawal in the light phase ( Fig. 8: F(2, 77) = 3.212, p = 0.0457). Post hoc analysis revealed that delta power was reduced in vapor-2BC mice (p = 0.012), compared to na€ ıve mice. The group effect was not significant in the dark phase, F(2, 77) = 2.9, p = 0.06. Example traces illustrate this finding (Fig. 9) . No differences were observed in the power spectra of theta, alpha, beta, and gamma bands during W, and in the theta bands in REM sleep. In addition, there were no significant effects involving sex on these measures.
DISCUSSION
First of all, these results indicated that, although they drink more EtOH overall, female C57BL/6J mice develop escalated EtOH drinking with CIE exposure to an equal degree as males. This is consistent with our previous findings (Bray et al., 2017) as well as others (Bergeson et al., 2016; Crabbe et al., 2012) . Another recent study showed escalated EtOH drinking in male C57BL/6J mice, but not in females (Jury et al., 2016) ; however, these results were based on 24-hour EtOH drinking as opposed to the limited-access model most commonly associated with CIE models. It is possible that the patterns of intake across the 24-hour periods were altered by CIE or that there was some sort of ceiling effect in the females.
Findings from the present study showed that chronic passive exposure to EtOH vapor, together with the limitedaccess EtOH/water choice procedure, causes alterations in the states of sleep in mice 4 days following withdrawal. For the most part, the control-2BC and na€ ıve groups looked quite similar and this was born out statistically. However, in the cases of latencies to SWS (Fig. 6A ) and EEG power density (Fig. 8) it appeared that nondependent limited-access EtOH drinking had subtle effects. For example, the latencies to SWS of control-2BC mice appeared more similar to those of vapor-2BC mice than na€ ıve mice. In addition, EEG power densities of male control-2BC mice appeared identical to vapor-2BC mice. We were intentionally focusing on protracted abstinence in dependent mice for this experiment and therefore tested the mice 4 days postvapor, meaning that the control-2BC mice had been EtOH free for just over 3 weeks. While it is surprising that this group would show effects on sleep at this time point, it is true that they did drink quite a bit of EtOH throughout the experiment, in many cases consistent with binge-like levels. We are currently studying the effects of binge-like EtOH consumption on sleep parameters were compared using a 2-way ANOVA. There were no significant effects of group on these measures. Values (mean AE SEM) were compared using a 2-way ANOVA and Fisher's PLSD tests. There was an overall sex difference and SWS latency of vapor-2BC females was significantly greater than that of na€ ıve mice and REM latency of vapor-2BC females was significantly greater than both control groups. *p < 0.05 versus na€ ıve, ***p < 0.05 versus control-2BC and na€ ıve, sexes analyzed separately.
in female and male mice so we should be able to shed more light on this interesting finding.
We observed subtle, but significant sex differences in the effects of EtOH vapor plus drinking that suggest at least partially differential mechanisms to this end. Our results showed that the reduction in the total amount of SWS in males was associated with a reduction in the mean duration and an increase in the number of the SWS episodes, suggesting abnormalities in the mechanisms of maintenance of sleep. In contrast, the disruptions in the amount of SWS in vapor-2BC female mice were associated with an increased latency to sleep, suggesting abnormalities in the mechanisms of triggering of sleep. These findings suggest possible impairments in maintenance of sleep in vapor-2BC male mice and triggering of sleep in vapor-2BC female mice.
Importantly, we observed an overall reduction in delta power in vapor-2BC mice, suggesting that in addition to the effects of EtOH on the mechanism that regulate sleep, the quality of sleep at 4 days of EtOH withdrawal is affected. Slow-wave activity, also known as SWA (EEG frequency band between 0.75 and 4.0 Hz), increases with lengthening wake duration and dissipates during SWS and has been generally accepted as an index of sleep homeostasis (Borbely et al., 1984) . Therefore, a significant decrease in sleep quality is characterized by increases in sleep fragmentation and decreased SWA, both observed in vapor-2BC mice. These results suggest that EtOH dependence disrupts sleep quality in addition to sleep quantity. These findings are consistent with previous studies carried out in male rats in which reductions in the amount of sleep and the alterations in delta power have been observed during EtOH withdrawal (Criado et al., 2008; Ehlers and Slawecki, 2000) .
Several studies have shown that male rats have enhanced seizure susceptibility, more anxiety-like responses in the social interaction test, bigger increases in acoustic startle responses, longer recovery to normal EtOH-induced loss of righting reflex times, and more impaired body temperature rhythms than females during EtOH withdrawal. Based on these studies, it has been proposed that male rodents have both slower recovery and greater severity of withdrawal (Becker and Koob, 2016; Veatch et al., 2007; Walls et al., 2012) . In contrast, Bekman and colleagues (2013) and Hommer (2003) reported that women have greater vulnerability toward EtOH withdrawal-induced harm than men and that high-dose drinking is associated with more severe negative effects that take longer to resolve in women following heavy drinking episodes and lead to more rapid development of neurotoxicity and alcoholic liver disease (Hommer, 2003) . Interestingly, our EEG recordings of sleep showed that at 4 days of withdrawal vapor-2BC mice had lower amounts of SWS than control mice during the light and dark phases, with no overall sex differences. However, it is possible that different mechanisms underlie this difference, as males had increased numbers of sleep episodes with decreased episode duration and females showed increased latency to sleep. The male finding suggests fragmented sleep, whereas the female finding suggests possible characteristics of insomnia.
It is well known that an intricate neurocircuitry consisting of neurochemicals in distinct nuclei residing in the basal forebrain, preoptic area, lateral hypothalamus, and brain stem is responsible for the induction and maintenance of arousal Values (mean AE SEM) were compared using a 2-way ANOVA and Fisher's PLSD tests. Vapor-2BC mice had decreased delta power relative to na€ ıve mice during the light phase. §p < 0.05 versus na€ ıve, sexes combined. Fig. 9 . Representative tracings of slow-wave sleep (SWS) recorded in 2 na€ ıve mice (a male and a female), and 2 vapor-2BC-treated animals (a male and a female). Note that independent of sex, vapor-2BC treatment was associated with a reduction in the slow-wave characteristic of SWS compared to na€ ıve animals. Electroencephalographic traces represent 15 seconds of recording.
and SWS sleep (Jones, 2005; Siegel, 2011; Szymusiak and McGinty, 2008) . Some reports suggest that there are sex differences in the hormonal modulation of both the activity of sleep nuclei and the expression of the sleep neurorelated substances. For example, Hadjimarkou and colleagues (2008) reported that female rats treated with estradiol showed a significant reduction in neuronal activity of ventrolateral preoptic area neurons (VLPOs) in the hypothalamus. During SWS, the sleep-active neurons in the VLPO cluster inhibit the activity of the neurons in the tuberomammillary, dorsal raphe, and locus coeruleus nuclei by releasing galanin and GABA, thus maintaining SWS (Saper et al., 2010) . Interestingly, an increase in progesterone, estrogen, and estradiol levels in female rats and guinea pigs correlates with a reduction in the amount of SWS and REM sleep, as well as with a reduction in the slow-wave activity (0.4 to 4 Hz) during SWS (Deurveilher et al., 2011) . Furthermore, there is evidence that EtOH intoxication and EtOH withdrawal elicit a rapid rise in the levels of plasma corticosterone in male, but not female rodents (Janis et al., 1998) , whereas levels of both progesterone and the neuroactive steroid allopregnanolone are significantly higher in the brains of female rats relative to male rats (Tanchuck-Nipper et al., 2015) . Therefore, in view of these studies, it is possible that hormonal differences between sexes play a role in the differential sleep disturbances observed in this study.
CONCLUSIONS
Sleep quantity and quality were disrupted 4 days into EtOH withdrawal in both female and male mice; however, there were sex differences in the type of disruption. Female mice appeared to be more affected with regard to latency to sleep, while male mice appeared more sensitive to sleep episode characteristics. Because sleep disturbances are considered so important in continued EtOH drinking and relapse, this model will be of great importance in examining possible therapeutics. Future work will examine the effects of target compounds on sleep and drinking and further explore the relationship between these sleep disturbances and escalated EtOH drinking associated with dependence. In addition, this model can be used to further explore the mechanisms underlying sex differences in the sleep disturbances associated with EtOH dependence and withdrawal.
